Policy analysis reviews European PFAS restrictions and regulatory timelines, highlighting significant operational impacts on Japanese fluorinated coating manufacturers.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Naka HIRAYAMA (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: